Inventor

Gerald E. Stokker

Inventor
Gwynedd Valley, PA, US

Overview

46→
Patents
1977–2003
Patent span
Chemistry
Primary field (CPC C)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
C07CAcyclic or carbocyclic compounds21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07KPeptides5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
C12NMicroorganisms or enzymes3%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms3%
PatentTitleYear
6,566,385'Inhibitors of prenyl-protein transferase'20036,562,823'Inhibitors of prenyl-protein transferase'20036,358,985'Inhibitors of prenyl-protein transferase'20026,358,956'Inhibitors of prenyl-protein transferase'20026,284,755'Inhibitors of prenyl-protein transferase'20016,080,870'Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors'20006,063,930'Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors'2000RE036520'HMG-CoA reductase inhibitors'2000RE036481'HMG-CoA reductase inhibitors'20005,977,134'Inhibitors of farnesyl-protein transferase'19995,710,171'Bisphenyl inhibitors of farnesyl-protein transferase'19985,661,161'Inhibitors of farnesyl-protein transferase'19975,652,257'Heterocycle-containing inhibitors of farnesyl-protein transferase'19975,631,280'Inhibitors of farnesyl-protein transferase'19975,585,359'Inhibitors of farnesyl-protein transferase'19965,576,293'Inhibitors of farnesyl-protein transferase'19965,523,456'Inhibitors of farnesyl-protein transferase'19965,362,906'Farnesyl pyrophosphate analogs'19945,298,655'Farnesyl pyrophosphate analogs'19945,116,870'HMG-CoA reductase inhibitors'19925,053,525'Oxo-analogs of mevinolin-like antihyper-cholesterolemic agents'19915,041,562'3-keto HMG-CoA reductase inhibitors'19915,021,453'3-keto HMG-CoA reductase inhibitors'19915,001,241'3-KETO HMG-CoA reductase inhibitors'19914,968,693'3-keto HMG-COA reductase inhibitors'19904,940,727'Novel HMG-CoA reductase inhibitors'19904,902,709'Novel antihypercholesterolemic compounds'19904,855,321'Antihypercholesterolemic compounds'19894,789,682'Antihypercholesterolemic compounds'19884,772,626'Antihypercholesterolemic compounds'19884,588,820'Process for epimerization at C.sub.6 of 3,4,5,6-tetrahydro-2H-pyran-2-one'19864,356,314'[5,6,9A-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoi c and cycloalkanoic acids, their analogs, esters, salts, and derivatives'19824,356,313'[(5,6,9a-substituted-3-oxo-1,2,9,9a-tet rahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acid esters and their analogs, the parent acids and their salts'19824,337,354'[(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkano ic and cycloalkanoic acids, their analogs, esters, salts, and derivatives'19824,317,922'[(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahy dro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids and their analogs, esters, salts and derivatives'19824,316,043'[(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alka noic and cycloalkanoic acids and their analogs, esters, salts and derivatives'19824,308,378'Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one s'19814,221,790'Substituted 2,2-dioxo-1,2,3-benzoxathiazines'19804,166,177'Substituted 2,2-dioxo-1,2,3-benzoxathiazines'19794,159,279'Nuclear substituted 2-hydroxyphenylmethanesulfamic acids'19794,156,005'Derivatives of 1,2-benzisoxazoles'19794,123,537'2-Halo-4-aminomethyl-6-alkyl-3-pyridinols useful as diuretics in treating hypertension and edema'19784,113,877'Substituted 2-aminomethylphenyl sulfamates'19784,092,414'3,4-Dihydrospiro-2H-1,3-benzoxazines and their use in treating edema, abnormal electrolyte retention, and inflammation'19784,067,980'Spirobenzoxazinium salts, method of use and compositions thereof as antihypertensive agents'19784,003,927'(1-Oxo-7,8-disubstituted-1,2,3,4-tetrahydro-6-naphthyloxy)- and (3,4-disubstituted-5-oxo-6,7,8,9-tetrahydro-5H-benzocycloheptene-2-yloxy ) acetic acids and derivatives'1977

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1977–2003Patents assigned to MERCK & CO INC (46)· patent assignee history
1977–2003Based in Gwynedd Valley, PA, US· patent location history
1988Based in Garnet Valley, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK & CO INC461977–2003
Locations
LocationPatentsSpan
Gwynedd Valley, Pennsylvania, US451977–2003
Garnet Valley, Pennsylvania, US11988